Last reviewed · How we verify
Efficacy and Safety of AngongNiuhuang Pill in Patients With Acute Ischemic Stroke (ANGONG TRIAL)
AngongNiuhuang pill has obvious effects on the cardiovascular and cerebrovascular diseases. Pharmacological experiments confirmed that AngongNiuhuang pill can protect blood-brain barrier, inhibit capillary permeability, improve the tolerance of cerebral ischemia and hypoxia, reduce oxidative stress injury, thus protecting brain tissue. Clinical studies have also confirmed that AngongNiuhuang pill can increase the GCS score, reduce coma, improve nerve function defect and promote nerve function recovery. The primary purpose of this trial was to evaluate the difference in the volume of cerebral infarction and cerebral edema between Angong Niuhuang pill and placebo in patients with ischemic stroke at 14 days compared with the baseline.
Details
| Lead sponsor | Peking Union Medical College Hospital |
|---|---|
| Phase | PHASE3 |
| Status | COMPLETED |
| Enrolment | 120 |
| Start date | Thu Oct 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Jul 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Acute Ischemic Stroke
Interventions
- AngongNiuhuang pill
- Placebo of AngongNiuhuang pill
- Standard treatment
Countries
China